Protein Expression Market 2024-2033: Growth Forecast & Competitive Landscape

The protein expression market size has grown rapidly in recent years. It will grow from $3.19 billion in 2023 to $3.56 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to scientific research, biopharmaceutical development, biotechnology advancements, drug discovery and development, healthcare industry growth.

The protein expression market size is expected to see rapid growth in the next few years. It will grow to $5.7 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to personalized medicine, biosimilars market, drug repurposing, regulatory support, precision agriculture. Major trends in the forecast period include cell-free expression systems, crispr-cas9 for gene editing, sustainable bioprocessing, contract research and manufacturing, multi-modal expression platforms.

Market Overview -
Protein expression is a process in which proteins are synthesized, modified, regulated, and controlled in living organisms according to the host cell. Protein expression in the context of protein research can now also refer to the application of lab procedures necessary for protein production.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=2493&type=smp

Growing Demand For Biologics Boosts The Protein Expression Market
An increase in demand for biologics to counter various genetic disorders and chronic diseases is one the major factors driving the research and sales of protein expression market. Biologics is a medicine produced from living organisms or contains components of living organisms such as protein, tissue, genes, allergens, cells, blood components, blood, and vaccines. The increasing use of biologics (therapeutic protein and others) to cure chronic diseases such as cancer, cardiovascular conditions and genetic disorders, is increasing the demand for protein expression devices and equipment. For instance, in September 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. Hence the rising demand for biologics is driving the protein expression market. For instance, according to an article published by Chemistry World, analysts stated that the biologics market hold a market share of more than a quarter of the entire pharmaceutical market in 2020. The global biologics market is expected to grow at 14.7% during 2021-2023.

Competitive Landscape -
Major companies operating in the protein expression market include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., New England Biolabs Inc., Promega Corporation, Qiagen NV, Takara Bio Inc., Merck KGaA, Genscript Biotech Corporation, Life Technologies Corporation, Sigma-Aldrich Corporation, Lucigen Corporation, Synthetic Genomics Inc., Becton, Dickinson & Company, Lonza Group Ltd., Geneva Biotech LLC, Viva Biotech Holdings, Sengenics LLC, ARTES Biotechnology GmbH, Addgene Inc., Profacgen, ProteoGenix Inc., Peak Proteins Ltd., Domainex Ltd., Jena Bioscience GmbH, EMD Millipore Corporation, Oxford Expression Technologies Ltd., Creative Biolabs Inc., Abnova Taiwan Corp, Accelagen Inc.

Next-Generation Protein Expression Solutions In The Market
Major companies operating in the protein expression market are increasing their focus on introducing next-generation solutions, such as Visium CytAssist Gene and Protein Expression Assay, to maximize their revenues in the market. Next-generation solutions refer to the use of advanced technologies and techniques to improve the efficiency, accuracy, and speed of protein expression. For instance, in May 2023, 10x Genomics Inc., a US-based biotechnology company, launched the Visium CytAssist Gene and Protein Expression Assay to allow researchers to study the relative expression patterns of proteins within the human immune system. With Visium's unique morphology-first approach, H&E (Hematoxylin and Eosin) staining can be done before any chemical treatments are applied to the tissue section. This enables three-dimensional spatial analysis on the exact same sample while allowing researchers to investigate the morphology of their tissue on the same slice they use for deeper spatial multiomic inquiry. Utilizing a sequencing-based readout, Visium CytAssist Gene and Protein Expression enables the simultaneous collection of protein and entire transcriptome gene expression with histological analysis in a single experiment from a single tissue section.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Key Segments -
The protein expression market covered in this report is segmented -
1) By Protein Expression: Yeast Expression, Mammalian Expression, Algae Expression, Insect Expression, Bacterial Expression, Cell-free Expression
2) By Product: Reagents, Competent Cells, Expression vectors, Services, Instruments
3) By Application: Therapeutic, Industrial, Research
4) By End Use: Pharmaceutical And Biotechnological Companies, Academic Research, Contract Research Organizations

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.